2BBBullish & Bearish
Bio-Rad Laboratories, Inc (BIO) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 53 out of 100.
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.
Bio-Rad Laboratories, Inc’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 58 | Moderate |
| Momentum | 41 | Stable |
| Financial strength | 65 | Strong |
| Quality | 97 | Very Strong |
| Risk | 14 | Very Low |
| CEO | Norman David Schwartz |
| Headquarters | Hercules, California, United States |
| Founded | 1952 |
| Employees | 7.45K |
| P/E ratio | 43.94 |
| 52-week range | $236.73 – $396.23 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-10 | — | 3.0334 | — | $696.29M |
| 2026-10-22 | — | 2.2119 | — | $655.49M |
| 2026-08-04 | — | 1.7652 | — | $630.23M |
| 2026-04-30 | 1.89 | 2.0038 | $592.10M | $594.76M |